Skip to Content
Merck
CN
  • Parallel in vivo analysis of large-effect autism genes implicates cortical neurogenesis and estrogen in risk and resilience.

Parallel in vivo analysis of large-effect autism genes implicates cortical neurogenesis and estrogen in risk and resilience.

Neuron (2021-01-27)
Helen Rankin Willsey, Cameron R T Exner, Yuxiao Xu, Amanda Everitt, Nawei Sun, Belinda Wang, Jeanselle Dea, Galina Schmunk, Yefim Zaltsman, Nia Teerikorpi, Albert Kim, Aoife S Anderson, David Shin, Meghan Seyler, Tomasz J Nowakowski, Richard M Harland, A Jeremy Willsey, Matthew W State
ABSTRACT

Gene Ontology analyses of autism spectrum disorders (ASD) risk genes have repeatedly highlighted synaptic function and transcriptional regulation as key points of convergence. However, these analyses rely on incomplete knowledge of gene function across brain development. Here we leverage Xenopus tropicalis to study in vivo ten genes with the strongest statistical evidence for association with ASD. All genes are expressed in developing telencephalon at time points mapping to human mid-prenatal development, and mutations lead to an increase in the ratio of neural progenitor cells to maturing neurons, supporting previous in silico systems biological findings implicating cortical neurons in ASD vulnerability, but expanding the range of convergent functions to include neurogenesis. Systematic chemical screening identifies that estrogen, via Sonic hedgehog signaling, rescues this convergent phenotype in Xenopus and human models of brain development, suggesting a resilience factor that may mitigate a range of ASD genetic risks.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
TG003, ≥98% (HPLC)
Sigma-Aldrich
SAG dihydrochloride, ≥98% (HPLC)